Navigation
Navigation
User login
Back to top

The Haematological Malignancy Research Network provides information about leukaemias, lymphomas, myelomas, and related blood disorders. Our statistics are based on data from the UK, and use the World Health Organization’s Classification for Oncology (ICD-O-3) which currently recognises over 100 different haematological malignancy subtypes.

If you are a participant in our research, you can find more information on our patient hub, YHHN.org.

What's new?

Our new site is live!

Take a tour through the new features and content.

New features

New publication

We found that people with monoclonal gammopathy of undetermined significance (MGUS) have increased hospital activity compared with the general population, up to 5 years before their diagnosis. This supports the view that, in some individuals, MGUS can have severe health consequences, extending over many years.

View our publications list

Network members

NHS haematology staff in the HMRN clinical network can access the Members' section here (active HMRN account required)

Visit members section